Introduction

19:15-19:30

Clinical challenges in Systemic Sclerosis c - PAH

J Allanore

19:30-19:45

Novel targets in vascular biology: scleroderma and spectrum of disease

O Distler

19:45-20:15

Systemic Sclerosis – PAH: potential approaches in pharmacotherapy

 J-L Vachiery

20:15-20:30

Trial design and feasibility in scleroderma associated PAH

J Seibold

20:30-20:45

&  A session – Panel discussion